Eur Heart J:HIV感染与胸腹主动脉瘤相关

2021-07-08 MedSci原创 MedSci原创

与未感染的对照者相比,PLWH患主动脉瘤的几率高出四倍,并且HIV状态与主动脉瘤独立相关。在PLWH中,年龄、肥胖和合并乙型肝炎感染与较高的主动脉瘤发生几率相关。

HIV感染者(PLWH)中主动脉瘤的患病率尚未明确。

近日,血管领域权威杂志Eur Heart J上发表了一篇研究文章,研究人员旨在明确HIV状态是否与主动脉瘤独立相关。此外,研究人员旨在确定与PLWH主动脉瘤相关的危险因素。


研究人员从哥本哈根HIV感染合并症研究中招募了年龄40岁以上的PLWH患者(n=594),并与来自哥本哈根一般人群研究的未感染对照者(n=1188)进行年龄和性别匹配。研究人员使用对比增强计算机断层扫描评估了主动脉尺寸。根据欧洲心脏病学会指南定义了主动脉瘤,即主动脉扩张≥50%或肾下主动脉直径≥30mm。

在PLWH和未感染的对照者中,年龄中位数(四分位距)分别为52(47-60)和52(48-61),88%和90%为男性。研究人员在42名(7.1%)PLWH中发现了46处动脉瘤,在29名(2.4%)未感染的对照者中发现了31处动脉瘤(P<0.001)。PLWH的升主动脉瘤和肾下主动脉瘤的患病率明显较高。在调整后的模型中,HIV与主动脉瘤独立相关(调整后的比值比为4.51[95%置信区间为2.56–8.08],P<0.001)。在PLWH中,肥胖和乙型肝炎合并感染与主动脉瘤相关。
 
由此可见,与未感染的对照者相比,PLWH患主动脉瘤的几率高出四倍,并且HIV状态与主动脉瘤独立相关。在PLWH中,年龄、肥胖和合并乙型肝炎感染与较高的主动脉瘤发生几率相关。

原始出处:

Julie Høgh.et al.HIV infection is associated with thoracic and abdominal aortic aneurysms: a prospective matched cohort study.European Heart Journal.2021.https://doi.org/10.1093/eurheartj/ehab348

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1357735, encodeId=9c7a135e735bc, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Jul 10 06:57:01 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1415761, encodeId=1a7e1415e61db, content=<a href='/topic/show?id=04812314540' target=_blank style='color:#2F92EE;'>#主动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23145, encryptionId=04812314540, topicName=主动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77603112682, createdName=circumcision, createdTime=Sat Jul 10 06:57:01 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429082, encodeId=e4261429082da, content=<a href='/topic/show?id=ee192321560' target=_blank style='color:#2F92EE;'>#主动脉瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23215, encryptionId=ee192321560, topicName=主动脉瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95e34160730, createdName=fengting4, createdTime=Sat Jul 10 06:57:01 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563484, encodeId=35b71563484d8, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sat Jul 10 06:57:01 CST 2021, time=2021-07-10, status=1, ipAttribution=)]
    2021-07-10 zhaojie88
  2. [GetPortalCommentsPageByObjectIdResponse(id=1357735, encodeId=9c7a135e735bc, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Jul 10 06:57:01 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1415761, encodeId=1a7e1415e61db, content=<a href='/topic/show?id=04812314540' target=_blank style='color:#2F92EE;'>#主动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23145, encryptionId=04812314540, topicName=主动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77603112682, createdName=circumcision, createdTime=Sat Jul 10 06:57:01 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429082, encodeId=e4261429082da, content=<a href='/topic/show?id=ee192321560' target=_blank style='color:#2F92EE;'>#主动脉瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23215, encryptionId=ee192321560, topicName=主动脉瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95e34160730, createdName=fengting4, createdTime=Sat Jul 10 06:57:01 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563484, encodeId=35b71563484d8, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sat Jul 10 06:57:01 CST 2021, time=2021-07-10, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1357735, encodeId=9c7a135e735bc, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Jul 10 06:57:01 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1415761, encodeId=1a7e1415e61db, content=<a href='/topic/show?id=04812314540' target=_blank style='color:#2F92EE;'>#主动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23145, encryptionId=04812314540, topicName=主动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77603112682, createdName=circumcision, createdTime=Sat Jul 10 06:57:01 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429082, encodeId=e4261429082da, content=<a href='/topic/show?id=ee192321560' target=_blank style='color:#2F92EE;'>#主动脉瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23215, encryptionId=ee192321560, topicName=主动脉瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95e34160730, createdName=fengting4, createdTime=Sat Jul 10 06:57:01 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563484, encodeId=35b71563484d8, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sat Jul 10 06:57:01 CST 2021, time=2021-07-10, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1357735, encodeId=9c7a135e735bc, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Jul 10 06:57:01 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1415761, encodeId=1a7e1415e61db, content=<a href='/topic/show?id=04812314540' target=_blank style='color:#2F92EE;'>#主动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23145, encryptionId=04812314540, topicName=主动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77603112682, createdName=circumcision, createdTime=Sat Jul 10 06:57:01 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429082, encodeId=e4261429082da, content=<a href='/topic/show?id=ee192321560' target=_blank style='color:#2F92EE;'>#主动脉瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23215, encryptionId=ee192321560, topicName=主动脉瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95e34160730, createdName=fengting4, createdTime=Sat Jul 10 06:57:01 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1563484, encodeId=35b71563484d8, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=80d715270048, createdName=slcumt, createdTime=Sat Jul 10 06:57:01 CST 2021, time=2021-07-10, status=1, ipAttribution=)]
    2021-07-10 slcumt

相关资讯

JAHA:PCSK9抑制剂可改善HIV携带者冠脉健康

PCSK9(前蛋白转化酶枯草杆菌素9型)因其在胆固醇代谢中的重要作用而被熟知。PCSK9水平的升高可增加心血管疾病风险,PCSK9抑制剂(PCSK9i)可以降低冠心病患者的心血管事件发生率。PCSK9

Neurology: 艾滋病患者,脑白质病变比普通人更明显

艾滋病患者,脑白质病变比普通人更明显

Clin Infect Dis:妊娠期抗逆转录病毒治疗可增加宝宝出生后的心血管疾病风险

全球约3800万人感染了HIV,约一半为女性。HIV感染女性妊娠期间进行ART治疗可预防母婴传播,但母体HIV感染和ART双重打击暴露对胎儿的发育会有什么影响呢?

NEJM:广泛中和抗体用于HIV感染的预防

虽然证明了广泛中和抗体可预防HIV感染这一概念,但VRC01对HIV-1感染的预防效果不显著

JAHA:急性冠脉综合征后HIV感染与长期心血管风险之间的关系

尽管PLHIV和HIV未感染者之间发生重大不良心脏和脑血管事件的总体风险在统计学上无显著差异,但PLHIV发生复发性ACS的几率更高。

JAHA:抑郁是HIV感染者发生缺血性卒中的危险因素

在调整社会人口学特征、传统脑血管危险因素和HIV特异性因素后,抑郁症与HIV阳性人群卒中风险增加相关。抑郁症可能是HIV感染者发生缺血性卒中的一个新的、独立的危险因素,尤其是在年轻人中。